Oxford BioMedica PLC (OXB)

Back to homepage

Company Description

Oxford BioMedica PLC was incorporated on September 20, 1996. The Company is a biopharmaceutical company. The Company is engaged in gene therapy and immunotherapy with a platform of technologies to design, develop and manufacture gene-based medicines. Its technology platform includes a LentiVector(r) gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a tumour antigen (5T4), which is an ideal target for anti-cancer therapy. The Company operates in Europe and internationally...